Services
Expertises
Resources
Who we are
Closed

Capital Access Advisory Program (CAAP) — Building Companies

Support for Ontario bioscience companies raising capital

Source change captured

Funding available
Varies by project
Deadline
Unspecified
Location
Ontario, Canada
Who can apply
Private, high-potential bioscience companies based in Ontario.
See full eligibility

Overview

OBIO’s CAAP® is a program for private, high-potential bioscience companies based in Ontario, designed to accelerate technology commercialization and support the path toward Series A financing and strategic partnerships. It focuses on business strategic planning, advanced fundraising strategies, and closing an investment round and business development contract.

At a glance

Funding available

Varies by project

Financing goals
  • Develop strategic partnerships
  • Strengthen organizational capacity
  • Access new markets
  • Ensure financial sustainability

Eligible candidates

Location
  • Ontario
Eligible Industries
All industries
Annual revenue
All revenue ranges
Organisation size
All organization sizes
Audience
  • Startups
Legal structures
For-profit business

Receipt of requests is now closed

Get notified about updates to this grant.

Availability timeline

2026
Periods: 1

Latest changes

CAAP page now shows alumni listings and removes application details

The CAAP Building Companies page removed the application notice, program description, eligibility text, and contact details, and now mainly shows company alumni listings.

See more

The Building Companies page no longer shows the “not currently accepting applications” notice, the program description, or the eligibility text that were previously visible. It also removed the contact name and email for the advisory program. The page now mainly presents CAAP Companies alumni sections, including a new CAAP Companies 2026 section and updated company listings across prior years.

Eligibility

Who is eligible?

  • Private, high-potential bioscience companies based in Ontario.
  • Companies focused on developing human health science products.
  • Companies starting to raise a post-seed financing round in the next 12-18 months.

Eligible geographic areas

  • Ontario

Activities funded

  • Technology commercialization for health science companies.
  • Strategic planning for a post-seed financing round.
  • Fundraising, financial modeling, and investment closing.
  • Participation in the OBIO Investment Summit and other international investment conferences.

How to apply

  • Step 1: Complete the online intake form
    • Access the application form provided by OBIO.
    • Enter the required organization and contact details.
    • Complete the form and submit it online.
  • Step 2: Await review
    • OBIO reviews submitted applications.
    • Only selected companies are contacted for the next stage.

Selection criteria

  • High growth potential.
  • Readiness to raise post-seed financing.
  • Alignment with health science commercialization goals.
  • Management team engagement in the program.

Processing and Agreement

  • Applications are reviewed after submission.
  • Only selected companies move to the next stage.
  • No further decision details are provided.

Additional information

  • OBIO’s CAAP® creates high value deal flow for both companies and investors.
  • CAAP® culminates with a presentation at the OBIO® Investment Summit (OIS).

Contacts

Official sources

Add helloDarwin as a preferred source on Google

Frequently Asked Questions about the Capital Access Advisory Program (CAAP) — Building Companies Program

What is the Capital Access Advisory Program (CAAP) — Building Companies?

OBIO’s CAAP® is a program for private, high-potential bioscience companies based in Ontario, designed to accelerate technology commercialization and support the path toward Series A financing and strategic partnerships. It focuses on business strategic planning, advanced fundraising strategies, and closing an investment round and business development contract.

Who is eligible for the Capital Access Advisory Program (CAAP) — Building Companies program?

To be eligible for the Capital Access Advisory Program (CAAP) — Building Companies program, you must: Private, high-potential bioscience companies based in Ontario. Companies developing human health science products. Companies starting to raise a post-seed financing round in the next 12-18 months.

Who can I contact for more information about the Capital Access Advisory Program (CAAP) — Building Companies?

You can contact Ontario Bioscience Innovation Organization (OBIO) by email at parniantajbakhsh@obio.ca.

Where is the Capital Access Advisory Program (CAAP) — Building Companies available?

The Capital Access Advisory Program (CAAP) — Building Companies program is available the province of Ontario.

Is the Capital Access Advisory Program (CAAP) — Building Companies a grant, loan, or tax credit?

Capital Access Advisory Program (CAAP) — Building Companies is a Expert Advice

Who are the financial supporters of the Capital Access Advisory Program (CAAP) — Building Companies?

Capital Access Advisory Program (CAAP) — Building Companies is funded by Ontario Bioscience Innovation Organization (OBIO)